Polymyositis is clearly an inflammatory disease, and responds to therapy directed towards inflammation. (Christopher-Stine, Plotz 2004) ^[1.]

 

---

 

1. Christopher-Stine L, Plotz P. Inflammatory Myopathies Best Practice & Research Clinical Rheumatology Volume 18, Issue 3, Pages 331-344, June 2004 as found at http://www.bprclinrheum.com/article/S1521-6942(04)00035-X/abstract.
2. Hofseth, L. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Letters Volume 268, Issue 1 , Pages 10-30, 8 September 2008, as found at http://www.cancerletters.info/article/S0304-3835(08)00230-9/abstract.
3. Wanchu A, Khullar M, Sud A, et al. Nitric oxide production is increased in patients with inflammatory myositis. Nitric Oxide. 1999 Dec;3(6):454-8, as found at http://www.ncbi.nlm.nih.gov/pubmed/10637123.
4. Harald Schemppa H, Manfred Reimb M, Dornisch K et al. Chlorite-Hemoprotein Interaction as Key Role for the Pharmacological Activity of the Chlorite-based Drug WF10. Arzneimittelforschung 2001; 51(7): 554-562 found at www.thieme-connect.com/ejournals/abstract/10.1055/s-0031-1300079